Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 07, 2022 08:00 ET | Source: Cannabis Science Conference

Study Finds Cannabinoids Block COVID-19: Prof. Richard van Breemen from OSU to Keynote 7th Semi-Annual Cannabis Science Conference West in Long Beach, California

World’s Largest Scientific and Medical Cannabis Conference Welcomes World-renowned Researcher That Led Oregon State University Study on COVID-19 and Cannabinoids LONG BEACH, CA, Feb. 07, 2022 ...
November 29, 2021 16:05 ET | Source: Adagene, Inc.

Adagene Announces FDA Clearance of IND for Phase 1b/2 Trial of Anti-CTLA-4 Monoclonal Antibody ADG116 in Combination Therapy with Anti-PD-1 Antibody Pembrolizumab

SAN DIEGO and SUZHOU, China, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the...
November 16, 2021 08:45 ET | Source: Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study

EDISON, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic...
October 20, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Appoints Dry Eye Disease Expert and Accomplished Optometrist Dr. Kelly K. Nichols to its Medical Advisory Board

SAN DIEGO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
October 19, 2021 12:00 ET | Source: MedicalMine Inc./Charm Health

CharmHealth, MedicalMine's Cloud-Based Health-Tech Platform, Launches Integrated Real Time Prescription Benefits With Electronic-Prescribing for Controlled Substances

PLEASANTON, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- MedicalMine Inc.'s CharmHealth suite of products is a leading comprehensive solution including Electronic Health Records (EHR), Practice...
October 19, 2021 07:00 ET | Source: Cerecin

Cerecin raises $40 Million Series II and IIA financing to support its programs in neurological disorders

Prominent banks and institutional investors from South Korea follow an earlier cornerstone investment from Cerecin’s long-term partner, Nestlé.Proceeds will be used to fund product and pipeline...
October 05, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board

SAN DIEGO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological,...
June 16, 2021 07:00 ET | Source: Altimmune, Inc.

Altimmune Announces Positive Interim Data from ALT-801 Phase 1 Trial in Overweight and Obese Volunteers

Weight loss of 5.4% achieved at 6 weeks of treatment with 1.8 mg once weekly dose, surpassing the 2% pre-established treatment targetAscending multi-dose regimen well-tolerated without necessity for...
May 26, 2021 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009 Compound Proving Suppression of Melanoma Cells

SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological...
December 11, 2020 07:00 ET | Source: Altimmune, Inc.

Altimmune to Present at the 4th Annual NASH Summit 2020 Digital Conference

GAITHERSBURG, Md., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Dr. Scott Harris, Chief Medical Officer of...